JSPR Explores Strategic Alternatives, Evaluates Cost-Saving Measures to Preserve Cash, Considers Sale, Licensing, or Wind-Down of Operations
Jasper Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $0.83
+6.7% in 1h after detection
Post-detection moves
1h
+6.7%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS